Literature DB >> 22067008

A systematic review of issues around antenatal screening and prenatal diagnostic testing for genetic disorders: women of Asian origin in western countries.

Juping Yu1.   

Abstract

Antenatal screening has become standard practice in many countries. However, not all pregnant women choose to be tested. In the UK, the incidence of some birth defects is found to be higher in babies of Asian women than in those of women from other ethnic groups, while there is some evidence suggesting that ethnic minorities, especially Asian women, are less likely to undergo antenatal screening and prenatal diagnosis, the reasons for which are unclear. This study aims to identify and describe the literature on issues around antenatal screening and prenatal diagnostic testing for genetic disorders among women of Asian descent in western countries. The Medline, CINAHL, ASSIA and PsycInfo databases were searched for the period of 1995 and 2010. Twenty-one studies met the inclusion criteria and were therefore reviewed. In general, Asian women were found to hold favourable attitudes towards testing. However, they reported a poorer understanding of testing than white women and not being offered a test, and were less able to make informed choices. Asian women in the UK and Australia were found to be less likely than their white counterparts to have undergone prenatal diagnosis, while such differences were not found in the USA and Canada. The equity of access to quality antenatal care, alongside comprehensive well thought out antenatal screening programmes, can be assured if strategies are in place which actively involve all ethnic groups and take account of social and cultural appropriateness for the population served. An understanding of broad factors that inform women's decision-making on test uptake would help health professionals provide women and their families with more culturally sensitive information and support that they may additionally need to make more informed choices.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22067008     DOI: 10.1111/j.1365-2524.2011.01036.x

Source DB:  PubMed          Journal:  Health Soc Care Community        ISSN: 0966-0410


  13 in total

1.  Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?

Authors:  Caroline Silcock; Lih-Mei Liao; Melissa Hill; Lyn S Chitty
Journal:  Health Expect       Date:  2014-02-20       Impact factor: 3.377

2.  Pregnant Hispanic women's views and knowledge of prenatal genetic testing.

Authors:  Robin L Page; Christina Murphey; Yahyahan Aras; Lei-Shih Chen; Ryan Loftin
Journal:  J Genet Couns       Date:  2021-01-26       Impact factor: 2.537

3.  Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews.

Authors:  Neeltje M T H Crombag; Ynke E Vellinga; Sandra A Kluijfhout; Louise D Bryant; Pat A Ward; Rita Iedema-Kuiper; Peter C J I Schielen; Jozien M Bensing; Gerard H A Visser; Ann Tabor; Janet Hirst
Journal:  BMC Health Serv Res       Date:  2014-09-25       Impact factor: 2.655

4.  Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals.

Authors:  Melissa Hill; Jo-Ann Johnson; Sylvie Langlois; Hyun Lee; Stephanie Winsor; Brigid Dineley; Marisa Horniachek; Faustina Lalatta; Luisa Ronzoni; Angela N Barrett; Henna V Advani; Mahesh Choolani; Ron Rabinowitz; Eva Pajkrt; Rachèl V van Schendel; Lidewij Henneman; Wieke Rommers; Caterina M Bilardo; Paula Rendeiro; Maria João Ribeiro; José Rocha; Ida Charlotte Bay Lund; Olav B Petersen; Naja Becher; Ida Vogel; Vigdis Stefánsdottir; Sigrun Ingvarsdottir; Helga Gottfredsdottir; Stephen Morris; Lyn S Chitty
Journal:  Eur J Hum Genet       Date:  2015-11-18       Impact factor: 4.246

5.  Prenatal screening for congenital anomalies: exploring midwives' perceptions of counseling clients with religious backgrounds.

Authors:  Janneke T Gitsels-van der Wal; Judith Manniën; Lisanne A Gitsels; Hans S Reinders; Pieternel S Verhoeven; Mohammed M Ghaly; Trudy Klomp; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-19       Impact factor: 3.007

6.  Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study.

Authors:  Janneke T Gitsels-van der Wal; Pieternel S Verhoeven; Judith Manniën; Linda Martin; Hans S Reinders; Evelien Spelten; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2014-08-09       Impact factor: 3.007

7.  Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.

Authors:  Neeltje M T H Crombag; Hennie Boeije; Rita Iedema-Kuiper; Peter C J I Schielen; Gerard H A Visser; Jozien M Bensing
Journal:  BMC Pregnancy Childbirth       Date:  2016-05-26       Impact factor: 3.007

8.  Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study.

Authors:  Chuanlin Li; Leiyu Shi; Jiayan Huang; Xu Qian; Yingyao Chen
Journal:  BMC Health Serv Res       Date:  2016-01-14       Impact factor: 2.655

9.  The contribution of gestational age, area deprivation and mother's country of birth to ethnic variations in infant mortality in England and Wales: A national cohort study using routinely collected data.

Authors:  Yangmei Li; Maria A Quigley; Nirupa Dattani; Ron Gray; Hiranthi Jayaweera; Jennifer J Kurinczuk; Alison Macfarlane; Jennifer Hollowell
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

10.  Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies.

Authors:  An Chen; Henni Tenhunen; Paulus Torkki; Antti Peltokorpi; Seppo Heinonen; Paul Lillrank; Vedran Stefanovic
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-02       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.